🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kevin M. Elias

Harvard University

ORCID: 0000-0003-1502-5553

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.165Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1355

Top 70%

0.165DataRank

Top 70%2 citations

James W. Webber, Stephanie Alimena, Sudhanshu Mishra, Chad B. Sussman, Cameron E. Comrie +7 more

Papers

Driven by 14 papers — median percentile 30. Top paper: “Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer”.

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

Nature Communications(2022)10.1038/s41467-022-28389-3

N/A

0.723DataRank · unranked

123 citations

Nuppu Lyytikäinen, Julia Casado, Ella Anttila, Angéla Szabó, U.-M. Haltia +12 more

Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1355

Top 70%

0.165DataRank

Top 70%2 citations

James W. Webber, Stephanie Alimena, Sudhanshu Mishra, Chad B. Sussman, Cameron E. Comrie +7 more

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1090092

N/A

0.104DataRank · unranked

1 citations

Naoko Sasamoto, Mary K. Townsend, Tianyi Huang, Kathryn L. Terry, Allison F. Vitonis +6 more

Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125

The Journal of Immunology(2022)10.4049/jimmunol.2001095

N/A

0DataRank · unranked

21 citations

Bin Jia, Guangan Hu, Lojain Ibrahim Al Johani, Roberta Fritz-Klaus, James Dongjoo Ham +6 more

A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers

Frontiers in Oncology(2022)10.3389/fonc.2022.786154

N/A

0DataRank · unranked

6 citations

Konrad Pagacz, Stephen Fiascone, Konrad Stawiski, Nicole Holub, Kathleen T Hasselblatt +5 more

Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer

Journal of Ovarian Research(2022)10.1186/s13048-022-00957-7

N/A

0DataRank · unranked

3 citations

Germán González, Jawad Hoballah, Jeff Brooker, Sinyoung Jeong, Conor L. Evans +8 more

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Nature Communications(2023)10.1038/s41467-023-38925-4

N/A

0DataRank · unranked

20 citations

Urszula Smyczyńska, Konrad Stawiski, Zuzanna Nowicka, James W. Webber, Jakub Kaplan +12 more

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

Cancers(2023)10.3390/cancers15164128

N/A

0DataRank · unranked

8 citations

Allen Green, Marco Campisi, Minyue Chen, Iliana Gjeci, Navin R. Mahadevan +15 more

Non-invasive DNA methylation-based testing for the diagnosis of endometrial cancer

The Lancet Oncology(2023)10.1016/s1470-2045(23)00522-3

N/A

0DataRank · unranked

2 citations

Kevin M. Elias, Jessica D. St. Laurent

Sialyl-Tn serves as a potential therapeutic target for ovarian cancer

Journal of Ovarian Research(2024)10.1186/s13048-024-01397-1

N/A

0DataRank · unranked

15 citations

Jillian M. Prendergast, Justin Clark, Bianca Zarrella, Dominique T. Zarrella, Sarah J. Hill +11 more

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-1674

N/A

0DataRank · unranked

217 citations

Matthew P. Keany, Han Dong, Linah Al-Alem, Unnati M. Pandya, Suzan Lazo +22 more

Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.08.008

N/A

0DataRank · unranked

0 citations

Laura Wollborn, Sudhanshu Mishra, Allison F. Vitonis, Daniel W. Cramer, Ryan T. Phan +6 more

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3817

N/A

0DataRank · unranked

103 citations

Denise Chen, Rosario I. Corona, Zhuxuan Fu, Rajmohan Murali, Martin Köbel +33 more

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer

Cancers(2022)10.3390/cancers14133077

N/A

0DataRank · unranked

66 citations

Ashley Petersen, Timothy K. Starr, Xuan Pu, Melissa A. Geller, Robert C. Bast +8 more